Diabetes mellitus is a metabolic disease associated with abnormally high levels of glucose in the blood, which is caused by insufficient production of insulin or the inability of cells to use insulin. The lack of insulin generally is in contact with a...
Diabetes mellitus is a metabolic disease associated with abnormally high levels of glucose in the blood, which is caused by insufficient production of insulin or the inability of cells to use insulin. The lack of insulin generally is in contact with a destructive process affecting the insulin producing pancreatic b cells in type 1 diabetes and a steady decline of beta cells in type 2 diabetes. The previous study demonstrated that the aqueous extracts of Triticum aestivum attenuated blood glucose level in the streptozotocin (STZ)-induced diabetic mice, which is an animal model of human insulin-dependent type 1 diabetes.
This study demonstrates the regulating effects of non-starch polysaccharide isolated from T. aestivum (TAP) on insulin secretion in pancreatic b cells and on glucose homeostasis in STZ-induced diabetic mice. RINm5F pancreatic b cell line and isolated rat islets were used for insulin secretion activity. Level of Insulin was measured by enzyme-linked immunosorbent assay (ELISA), real-time RT-PCR, and 45Ca2+ uptake assay. For in vivo oral glucose tolerance test (OGTT) and anti-hyperglycemic activity, TAP was administrated orally to STZ-induced diabetic mice.
In this study, TAP (0.1 to 2 mg/ml) augmented glucose-stimulated insulin secretion in the presence of stimulatory glucose concentration (16.7 mM), but not basal concentration (1.1 mM) in a dose-dependent manner. Although TAP failed to enhance the high K+-induced insulin secretion, the insulinotropic effect of TAP was significantly inhibited by diazoxide, an opener of ATP-sensitive K+ channel blocking insulin release. TAP potentiated the insulin secretion induced by other secretagogues, such as IBMX and tolbutamide. Moreover, TAP significantly increased glucose-induced 45Ca2+ uptake and subsequently enhanced phosphorylation of extra cellular signal-regulated protein kinases (ERK1/2) and protein kinase C (PKC). In addition, specific inhibitors of ERK and PKC attenuated the increase in insulin secretion induced by TAP in RINm5F cells. On the other hand, when TAP was administrated to the fasted mice, it decreased the rise in blood glucose level after starch loading in OGTT, and increased the serum insulin level in mice. Furthermore, oral treatment of TAP markedly improved the blood glucose level through increase of serum insulin level in STZ-induced diabetic mice. Immunohistochemical staining of islet showed that TAP induced the increase in insulin-producing b cells compared to the vehicle control.
Overall, the results indicate that TAP has the stimulating effect on insulin secretion and production in the pancreatic b cells via K+channel closure, calcium influx, and activation of PKC and ERK1/2 signaling pathway. These findings suggest that TAP might be useful in the control of hyperglycemia in insulin-dependent diabetes mellitus through the action as insulin secretagogues.